Recruiting Retinitis Pigmentosa Studies in Detroit
Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
To evaluate the long-term safety and tolerability of oral dersimelagon....
Study of Bitopertin in Participants With EPP or XLP (APOLLO)
The goal of this clinical trial is to learn if bitopertin works and is safe to treat EPP or XLP in participants 12 years or older. The main questions it aims to answer are: * Whether bitopertin incre...
About Retinitis Pigmentosa Clinical Trials in Detroit
Retinitis pigmentosa (RP) is a group of inherited retinal diseases that cause progressive loss of photoreceptor cells in the retina, leading to vision loss. It typically begins with night blindness and progresses to tunnel vision. Gene therapy and retinal implants are areas of active research.
There are currently 2 retinitis pigmentosa clinical trials recruiting participants in Detroit, MICHIGAN. These studies are seeking a combined 451 participants. Research is being sponsored by Mitsubishi Tanabe Pharma America Inc., Disc Medicine, Inc. Clinical trial participation is free and participants receive study-related medical care at no cost.
Retinitis Pigmentosa Clinical Trials in Detroit — FAQ
Are there retinitis pigmentosa clinical trials in Detroit?
Yes, there are 2 retinitis pigmentosa clinical trials currently recruiting in Detroit, MICHIGAN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Detroit?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Detroit research site will contact you about next steps.
Are clinical trials in Detroit free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Detroit studies also compensate for your time and travel.
What retinitis pigmentosa treatments are being tested?
The 2 active trials in Detroit are testing new therapies including novel drugs, biologics, and treatment approaches for retinitis pigmentosa.
Data updated March 2, 2026 from ClinicalTrials.gov